Carbonyl stress and oxidatively modified proteins in chronic renal failure

被引:8
|
作者
Bargnoux, A. -S. [1 ,2 ]
Morena, M. [2 ,3 ]
Badiou, S. [1 ,2 ]
Dupuy, A. -M. [1 ]
Canaud, B. [1 ,2 ,3 ]
Cristol, J. -P. [1 ,2 ]
机构
[1] CHU Montpellier, Montpellier, France
[2] Univ Montpellier I, UFR Med, EA 4188, Montpellier, France
[3] Inst Format & Rech Dialyse, Montpellier, France
关键词
oxidative stress; carbonyl stress; AOPP; homocysteinrenal insufficiency; INTIMA-MEDIA THICKNESS; HEMODIALYSIS-PATIENTS; ADVANCED GLYCATION; END-PRODUCTS; PLASMA; ATHEROSCLEROSIS; MORTALITY; UREMIA; MYELOPEROXIDASE; INFLAMMATION;
D O I
10.1684/abc.2009.0295
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Oxidative stress is commonly observed in chronic renal failure patients resulting from an umbalance between overproduction of reactive oxygen species and impairement of defense mechanisms. Proteins appear as potential targets of uremia-induced oxidative stress and may undergo qualitative modifications. Proteins could be directly modified by reactive oxygen species which leads to amino acid oxydation and cross-linking. Proteins could be indirectly modified by reactive carbonyl compounds produced by glycoxidation and lipo-peroxidation. The resulting post-traductional modifications are known as carbonyl stress. In addition, thiols could be oxidized or could react with homocystein leading to homocysteinylation. Finaly, tyrosin could be oxidized by mycloperoxidase leading to advanced oxidative protein products (AOPP). Oxidatively modified proteins are increased in chronic renal failure patients and may contribute to exacerbate the oxidative stress/ inflammation syndrome. They have been involved in long term complications of uremia such as amyloidosis and accelerated atherosclerosis.
引用
收藏
页码:153 / 158
页数:6
相关论文
共 50 条
  • [1] Importance of oxidatively modified proteins in chronic renal failure
    Descamps-Latscha, B
    Witko-Sarsat, V
    [J]. KIDNEY INTERNATIONAL, 2001, 59 : S108 - S113
  • [2] Carbonyl stress in chronic renal failure
    Mimic-Oka, J
    Simic, T
    Reljic, Z
    Ille, K
    [J]. JUGOSLOVENSKA MEDICINSKA BIOHEMIJA-YUGOSLAV MEDICAL BIOCHEMISTRY, 2000, 19 (04): : 381 - 385
  • [3] CARBONYL ASSAYS FOR DETERMINATION OF OXIDATIVELY MODIFIED PROTEINS
    LEVINE, RL
    WILLIAMS, JA
    STADTMAN, ER
    SHACTER, E
    [J]. OXYGEN RADICALS IN BIOLOGICAL SYSTEMS, PT C, 1994, 233 : 346 - 357
  • [4] DETERMINATION OF CARBONYL CONTENT IN OXIDATIVELY MODIFIED PROTEINS
    LEVINE, RL
    GARLAND, D
    OLIVER, CN
    AMICI, A
    CLIMENT, I
    LENZ, AG
    AHN, BW
    SHALTIEL, S
    STADTMAN, ER
    [J]. METHODS IN ENZYMOLOGY, 1990, 186 : 464 - 478
  • [5] Carbonyl stress in chronic renal failure:: the effect of haemodialysis
    Dursun, E
    Dursun, B
    Süleyrnanlar, G
    Ozben, T
    [J]. ANNALS OF CLINICAL BIOCHEMISTRY, 2005, 42 : 64 - 66
  • [6] DETERMINATION OF CARBONYL GROUPS IN OXIDATIVELY MODIFIED PROTEINS BY REDUCTION WITH TRITIATED SODIUM-BOROHYDRIDE
    LENZ, AG
    COSTABEL, U
    SHALTIEL, S
    LEVINE, RL
    [J]. ANALYTICAL BIOCHEMISTRY, 1989, 177 (02) : 419 - 425
  • [7] Oxidatively modified proteins in aging and disease
    Beal, MF
    [J]. FREE RADICAL BIOLOGY AND MEDICINE, 2002, 32 (09) : 797 - 803
  • [8] Specificity of ubiquitination for oxidatively modified proteins
    Taylor, A
    Dudek, E
    Liu, Q
    Shang, F
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 : U384 - U384
  • [9] Specificity of ubiquitination for oxidatively modified proteins
    Dudek, E
    Shang, F
    Liu, Q
    Taylor, A
    [J]. FASEB JOURNAL, 2004, 18 (08): : C129 - C129
  • [10] Specificity of ubiquitination for oxidatively modified proteins
    Taylor, A
    Dudek, E
    Liu, Q
    Shang, F
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46